Equities

OLBA Healthcare Holdings Inc

  • Add to watchlist
  • Add to portfolio
  • Add an alert
2689:TYO

OLBA Healthcare Holdings Inc

Actions
Health CareMedical Equipment and Services
  • Price (JPY)2,110.00
  • Today's Change-14.00 / -0.66%
  • Shares traded2.70k
  • 1 Year change+1.20%
  • Beta0.3204
Data delayed at least 15 minutes, as of Feb 06 2026 06:30 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

OLBA Healthcare Holdings Inc, formerly Kawanishi Holdings Inc, is a Japan-based company mainly engaged in the medical equipment business. The Company operates through four business segments. The Medical Equipment segment is engaged in the sale of medical electrical equipment, pharmaceuticals, surgical instruments, implants and other medical equipment for clinics and hospitals. The Supply Process Distribution (SPD) segment is engaged in the provision of SPD systems that use information technology to manage goods information and purchase information. The Nursing Care Products segment is engaged in the sale and rental of home care beds and other nursing care equipment. The Import and Sale segment is engaged in the import and sale of medical equipment.

  • Revenue in JPY (TTM)124.48bn
  • Net income in JPY1.43bn
  • Incorporated1967
  • Employees1.39k
  • Location
    OLBA Healthcare Holdings Inc8F, Nihon-Seimei Okayama Bldg II1-1-3, Shimoishii, Kita-kuOKAYAMA-SHI 700-0907JapanJPN
  • Phone+81 862361112
  • Fax+81 862361113
  • Websitehttps://www.olba.co.jp
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Aso International Inc3.88bn470.10m7.19bn310.0015.562.4514.021.8547.1647.16389.31299.861.2416.267.6612,519,540.0014.96--16.69--45.12--12.11--7.0149.710.00--7.10--13.50------
JTEC Corp1.93bn45.31m8.41bn76.00185.243.1640.864.377.697.69326.97450.770.56051.7126.4925,335,010.001.321.761.491.9961.0259.572.353.782.5519.790.15410.00-4.2213.39-69.7629.84-17.34--
Koken Ltd11.18bn776.88m9.81bn321.0012.230.71548.210.8776157.25157.252,268.412,688.030.5421.913.1834,839,600.003.773.974.625.0745.8346.446.957.561.6721.320.293524.851.664.582.9914.21-2.196.96
Yamashita Health Care Holdings Inc63.77bn412.00m9.91bn613.0023.401.0915.480.1553165.78165.7825,574.613,576.032.4314.255.39104,027,700.001.562.244.396.5313.5013.100.6430.89750.945--0.0032.954.76-0.05346.216.0343.356.79
Create Medic Co Ltd13.57bn762.91m10.94bn1.00k12.920.60768.180.80687.6087.601,563.181,863.230.71481.824.9413,545,480.004.023.044.543.5844.6244.515.624.635.1741.710.045860.323.533.74445.963.0114.010.00
JMS Co Ltd68.14bn157.00m11.01bn5.47k69.540.26844.110.16156.406.402,780.131,658.270.81552.553.7912,458,400.000.06460.74270.09361.1023.0323.520.07930.88361.0841.060.388171.626.833.56347.22-46.21-1.640.00
DVx Inc55.33bn308.75m12.85bn334.0040.461.4311.900.232229.4629.465,278.63831.732.2417.684.12165,663,400.001.252.643.286.459.6011.080.5581.281.23--0.002563.099.752.42137.18-12.33-2.4315.81
Japan Medical Dynamic Marketing Inc24.58bn-1.05bn13.11bn538.00--0.519224.270.5331-40.02-40.02933.26953.320.72020.63684.3445,695,190.00-3.134.27-3.804.9459.9365.20-4.355.781.2812.480.180228.508.356.79-136.31---1.378.45
OLBA Healthcare Holdings Inc124.48bn1.43bn13.28bn1.39k8.811.066.350.1066241.07241.0721,003.792,008.322.7716.234.8089,362,800.003.173.439.9111.3911.2611.491.151.220.958266.630.225530.513.492.61-4.6834.3828.7114.87
Daiken Medical Co Ltd10.17bn981.12m15.22bn180.0014.001.7818.221.5034.1534.15353.89267.890.90354.564.9256,482,360.008.727.8611.8311.2538.7941.239.659.511.89183.100.193969.412.073.1511.035.01-0.18892.83
Hoshi Iryo-Sanki Co Ltd15.19bn1.46bn17.07bn500.0010.650.813115.831.12468.70468.704,866.416,137.370.619926.896.0430,379,100.006.006.007.337.6150.3348.989.679.193.22--0.0015.312.196.784.2114.77-18.276.96
Seed Co Ltd33.55bn1.38bn17.95bn985.0013.050.97173.820.53545.4445.441,108.41610.280.64592.487.2834,057,800.002.652.314.163.9444.8442.204.113.300.65357.070.576336.012.580.8892-44.3833.9912.644.56
Medius Holdings Co Ltd291.70bn1.41bn18.41bn2.61k13.070.91774.780.063163.3463.3413,103.95902.232.5418.644.99111,591,700.001.231.654.596.0311.9112.070.48340.64920.912616.510.563828.5711.126.5322.307.6516.287.39
Data as of Feb 06 2026. Currency figures normalised to OLBA Healthcare Holdings Inc's reporting currency: Japanese Yen JPY

Institutional shareholders

0.10%Per cent of shares held by top holders
HolderShares% Held
Dimensional Fund Advisors LPas of 08 Jan 20263.80k0.06%
Dimensional Fund Advisors Ltd.as of 30 Nov 20251.70k0.03%
Amova Asset Management Co., Ltd.as of 16 Jun 2025300.000.01%
State Street Global Advisors (Japan) Co. Ltd.as of 05 Mar 2024200.000.00%
Nomura Asset Management Co., Ltd.as of 29 Sep 2025100.000.00%
Resona Asset Management Co., Ltd.as of 10 Dec 2024100.000.00%
More ▼
Data from 30 Sep 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.